世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

抗ヒスタミン剤の世界市場に関する洞察、2028年までの予測


Global Antihistamine Medications Market Insights, Forecast to 2028

抗ヒスタミン剤は、花粉症、じんましん、結膜炎、虫さされや刺されなどのアレルギー症状を緩和するために使用されることが多い医薬品です。 報告書の概要 COVID-19のパンデミックとロシア・ウクライナ戦争の影... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年9月16日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

抗ヒスタミン剤は、花粉症、じんましん、結膜炎、虫さされや刺されなどのアレルギー症状を緩和するために使用されることが多い医薬品です。
報告書の概要
COVID-19のパンデミックとロシア・ウクライナ戦争の影響により、2022年に百万米ドルと推定される製品名の世界市場は、2028年までに百万米ドルの改訂サイズに達し、予測期間2022-2028年に年率%で成長すると予測されます。
抗ヒスタミン薬の米国市場は、2023年から2028年の予測期間中にCAGR %で、2022年の百万米ドルから2028年には百万米ドルに達すると推定されます。
抗ヒスタミン薬の中国市場は、2023年から2028年の予測期間において、2022年の100万ドルから2028年には100万ドルに達し、CAGRで増加すると推定されます。
抗ヒスタミン薬のヨーロッパ市場は、2023年から2028年の予測期間中にCAGR %で、2022年の百万ドルから2028年には百万ドルに達すると推定されます。
抗ヒスタミン薬の世界の主要メーカーは、Sanofi、Johnson And Johnson、Merck、Teva、GlaxoSmithKline、Bayer、Sun Pharma、UCB Pharma、長江医薬集団などです。2021年、世界の上位5社は売上高で約 %のシェアを占めていました。

レポート範囲
本最新レポートでは、産業構造、売上高、収益、価格、粗利率を調査しています。主要生産者の生産拠点、市場シェア、業界ランキング、プロフィールを掲載しています。最新の政府規制、市場情報、業界データにアクセスするため、一次調査および二次調査を実施しています。データは抗ヒスタミン薬メーカー、流通業者、エンドユーザー、業界団体、政府産業局、業界誌、業界専門家、第三者データベース、弊社内データベースから収集しました。
本レポートでは、各地域の抗ヒスタミン薬市場における主要企業の考察も行っています。さらに、世界の抗ヒスタミン薬市場の主要な推進要因や地域別の力学、業界内の現行動向についても解説しています。

主な対象企業
本セクションでは、研究者は、事業を行っている著名なプレーヤーと、激しい競争に対抗するために彼らが焦点を当てている戦略について包括的な分析を行っています。また、著名なプレイヤーの会社概要と市場シェア分析もこのセクションで提供しています。さらに、専門家は、各プレイヤーの包括的な分析を行っています。彼らはまた、2017年から2022年の期間、メーカーの信頼性の高い売上高、収益、価格、市場シェアとランクデータを提供しています。本レポートの支援により、キープレイヤー、ステークホルダー、その他の参加者は、ビジネスにおける最近および今後の動向を把握することができ、さらに効率的な選択を行うことができるようになります。本調査レポートで取り上げた主要企業は以下の通りです。
サノフィ
ジョンソン・アンド・ジョンソン
メルク
テバ
グラクソ・スミスクライン
バイエル
サンファーマ
UCBファーマ
長江医薬集団
海南ポリ製薬
重慶華邦製薬
ドーンレイ

市場セグメント
本レポートでは、主要セグメントである「タイプ別」と「アプリケーション別」について調査しています。本レポートでは、業界の専門家により、その有利性と成長の可能性が検討されています。また、本レポートでは、2017-2028年までの売上高、収益、平均価格の予測データを、タイプ別およびアプリケーション別セグメントに基づいて掲載しています。
抗ヒスタミン薬 タイプ別セグメント
経口
非経口剤
抗ヒスタミン薬の用途別セグメント
オンライン
オフライン

主要地域と国
本セクションでは、様々な地域と各地域で活動する主要企業に関する主要な洞察を提供します。特定の地域/国の成長を評価する際に、経済的、社会的、環境的、技術的、政治的な要因が考慮されています。また、読者は2017-2028年までの各地域・国の金額と売上高データを手にすることができます。
北アメリカ
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE

主要なドライバーと障壁
本レポートでは、読者が一般的な開発を理解するのに役立つように、影響の大きいレンダリング要因とドライバーを調査しています。さらに、このレポートには、プレイヤーの道を阻むブロックとして機能する可能性のある抑制と課題も含まれています。これは、ユーザーが気を配り、ビジネスに関連する情報に基づいた意思決定を行うために支援します。専門家はまた、今後のビジネスの展望に彼らの焦点を置いています。
COVID-19とロシア・ウクライナ戦争影響力分析
このセクションの読者は、抗ヒスタミン薬市場のシナリオがパンデミック、ポストパンデミック、ロシア・ウクライナ戦争中に世界中でどのように変化したかを理解することができます。この研究は、需要、消費、輸送、消費者行動、サプライチェーン管理、輸出入、生産などの側面の変化を視野に入れて行われます。また、業界の専門家は、今後数年間でプレイヤーに機会を創出し、業界全体を安定させるのに役立つ主要な要因を取り上げています。

レポートには以下の内容が含まれます。
抗ヒスタミン薬の世界市場の概要、売上、収益、価格などを報告します。2017年~2021年の歴史的な市場収益/売上データ、2022年の予測、2028年までのCAGRの予測により、世界市場の動向を分析します。
抗ヒスタミン薬の主要生産者を調査し、主要地域と国の売上高も記載しています。抗ヒスタミン薬の今後の市場可能性のハイライト、およびこの市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国への注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、イギリス、イタリア、中東、アフリカ、その他の国々の国別データおよび市場価値分析。

本レポートでは、2017年から2022年までのデータをもとに、抗ヒスタミン薬の売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当てます。世界の抗ヒスタミン薬市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、ステークホルダーが競争環境を理解し、より多くの洞察を得て、ビジネスと市場戦略をより良い方法で位置づけるのに役立ちます。
本レポートでは、2017年から2028年までのタイプ別、用途別のセグメントデータ、売上高、収益、価格を分析しています。抗ヒスタミン薬の売上、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
サノフィ、ジョンソンアンドジョンソン、メルク、テバ、グラクソ・スミスクライン、バイエル、サンファーマ、UCBファーマ、長江医薬集団など、世界の主要プレイヤーの説明的な企業プロフィール。

章の概要
第1章:レポートのスコープ、各市場セグメント(製品タイプ、アプリケーションなど)の市場規模、将来の発展可能性などのエグゼクティブサマリーを紹介します。市場の現状と、短中期および長期的な展開の可能性を高次元で把握できます。
第2章 抗ヒスタミン薬の売上(消費)、収益(世界、地域レベル、国レベル)。各地域および主要国の市場規模や発展可能性を定量的に分析し、世界各国の市場発展や今後の発展見通し、市場スペース、生産能力などを紹介しています。
第3章 抗ヒスタミン薬メーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章:製品タイプ別に様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展可能性を網羅し、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。
第5章:読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、アプリケーションに応じて様々な市場セグメントの分析、各市場セグメントの売上高、収益、平均価格、および開発ポテンシャルをカバーすることを提供します。
第6章:北米:タイプ別、用途別、国別、セグメント別の売上高と収益。
第7章:ヨーロッパ:タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。
第8章:アジア太平洋:タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。
第9章:中南米:タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。
第10章:中東・アフリカ:タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。
第11章:主要メーカーのプロフィールを提供し、製品説明や仕様、抗ヒスタミン薬の売上、収益、価格、粗利、最近の開発など、市場の主要企業の基本状況を詳細に紹介します。
第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客に関する分析。
第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析などを紹介します。
第14章:レポートの要点と結論。


ページTOPに戻る


目次

1 Study Coverage
1.1 Antihistamine Medications Product Introduction
1.2 Market by Type
1.2.1 Global Antihistamine Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Non-Oral
1.3 Market by Application
1.3.1 Global Antihistamine Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antihistamine Medications Sales Estimates and Forecasts 2017-2028
2.2 Global Antihistamine Medications Revenue Estimates and Forecasts 2017-2028
2.3 Global Antihistamine Medications Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antihistamine Medications Sales by Region
2.4.1 Global Antihistamine Medications Sales by Region (2017-2022)
2.4.2 Global Sales Antihistamine Medications by Region (2023-2028)
2.5 Global Antihistamine Medications Revenue by Region
2.5.1 Global Antihistamine Medications Revenue by Region (2017-2022)
2.5.2 Global Antihistamine Medications Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antihistamine Medications Sales by Manufacturers
3.1.1 Global Top Antihistamine Medications Manufacturers by Sales (2017-2022)
3.1.2 Global Antihistamine Medications Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antihistamine Medications in 2021
3.2 Global Antihistamine Medications Revenue by Manufacturers
3.2.1 Global Antihistamine Medications Revenue by Manufacturers (2017-2022)
3.2.2 Global Antihistamine Medications Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antihistamine Medications Revenue in 2021
3.3 Global Antihistamine Medications Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antihistamine Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antihistamine Medications Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antihistamine Medications Sales by Type
4.1.1 Global Antihistamine Medications Historical Sales by Type (2017-2022)
4.1.2 Global Antihistamine Medications Forecasted Sales by Type (2023-2028)
4.1.3 Global Antihistamine Medications Sales Market Share by Type (2017-2028)
4.2 Global Antihistamine Medications Revenue by Type
4.2.1 Global Antihistamine Medications Historical Revenue by Type (2017-2022)
4.2.2 Global Antihistamine Medications Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antihistamine Medications Revenue Market Share by Type (2017-2028)
4.3 Global Antihistamine Medications Price by Type
4.3.1 Global Antihistamine Medications Price by Type (2017-2022)
4.3.2 Global Antihistamine Medications Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antihistamine Medications Sales by Application
5.1.1 Global Antihistamine Medications Historical Sales by Application (2017-2022)
5.1.2 Global Antihistamine Medications Forecasted Sales by Application (2023-2028)
5.1.3 Global Antihistamine Medications Sales Market Share by Application (2017-2028)
5.2 Global Antihistamine Medications Revenue by Application
5.2.1 Global Antihistamine Medications Historical Revenue by Application (2017-2022)
5.2.2 Global Antihistamine Medications Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antihistamine Medications Revenue Market Share by Application (2017-2028)
5.3 Global Antihistamine Medications Price by Application
5.3.1 Global Antihistamine Medications Price by Application (2017-2022)
5.3.2 Global Antihistamine Medications Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antihistamine Medications Market Size by Type
6.1.1 North America Antihistamine Medications Sales by Type (2017-2028)
6.1.2 North America Antihistamine Medications Revenue by Type (2017-2028)
6.2 North America Antihistamine Medications Market Size by Application
6.2.1 North America Antihistamine Medications Sales by Application (2017-2028)
6.2.2 North America Antihistamine Medications Revenue by Application (2017-2028)
6.3 North America Antihistamine Medications Market Size by Country
6.3.1 North America Antihistamine Medications Sales by Country (2017-2028)
6.3.2 North America Antihistamine Medications Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Antihistamine Medications Market Size by Type
7.1.1 Europe Antihistamine Medications Sales by Type (2017-2028)
7.1.2 Europe Antihistamine Medications Revenue by Type (2017-2028)
7.2 Europe Antihistamine Medications Market Size by Application
7.2.1 Europe Antihistamine Medications Sales by Application (2017-2028)
7.2.2 Europe Antihistamine Medications Revenue by Application (2017-2028)
7.3 Europe Antihistamine Medications Market Size by Country
7.3.1 Europe Antihistamine Medications Sales by Country (2017-2028)
7.3.2 Europe Antihistamine Medications Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antihistamine Medications Market Size by Type
8.1.1 Asia Pacific Antihistamine Medications Sales by Type (2017-2028)
8.1.2 Asia Pacific Antihistamine Medications Revenue by Type (2017-2028)
8.2 Asia Pacific Antihistamine Medications Market Size by Application
8.2.1 Asia Pacific Antihistamine Medications Sales by Application (2017-2028)
8.2.2 Asia Pacific Antihistamine Medications Revenue by Application (2017-2028)
8.3 Asia Pacific Antihistamine Medications Market Size by Region
8.3.1 Asia Pacific Antihistamine Medications Sales by Region (2017-2028)
8.3.2 Asia Pacific Antihistamine Medications Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Antihistamine Medications Market Size by Type
9.1.1 Latin America Antihistamine Medications Sales by Type (2017-2028)
9.1.2 Latin America Antihistamine Medications Revenue by Type (2017-2028)
9.2 Latin America Antihistamine Medications Market Size by Application
9.2.1 Latin America Antihistamine Medications Sales by Application (2017-2028)
9.2.2 Latin America Antihistamine Medications Revenue by Application (2017-2028)
9.3 Latin America Antihistamine Medications Market Size by Country
9.3.1 Latin America Antihistamine Medications Sales by Country (2017-2028)
9.3.2 Latin America Antihistamine Medications Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antihistamine Medications Market Size by Type
10.1.1 Middle East and Africa Antihistamine Medications Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antihistamine Medications Revenue by Type (2017-2028)
10.2 Middle East and Africa Antihistamine Medications Market Size by Application
10.2.1 Middle East and Africa Antihistamine Medications Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antihistamine Medications Revenue by Application (2017-2028)
10.3 Middle East and Africa Antihistamine Medications Market Size by Country
10.3.1 Middle East and Africa Antihistamine Medications Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antihistamine Medications Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Johnson And Johnson
11.2.1 Johnson And Johnson Corporation Information
11.2.2 Johnson And Johnson Overview
11.2.3 Johnson And Johnson Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson And Johnson Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson And Johnson Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Overview
11.4.3 Teva Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Teva Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Overview
11.6.3 Bayer Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bayer Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Recent Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Corporation Information
11.7.2 Sun Pharma Overview
11.7.3 Sun Pharma Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sun Pharma Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharma Recent Developments
11.8 UCB Pharma
11.8.1 UCB Pharma Corporation Information
11.8.2 UCB Pharma Overview
11.8.3 UCB Pharma Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 UCB Pharma Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 UCB Pharma Recent Developments
11.9 Yangtze River Pharmaceutical Group
11.9.1 Yangtze River Pharmaceutical Group Corporation Information
11.9.2 Yangtze River Pharmaceutical Group Overview
11.9.3 Yangtze River Pharmaceutical Group Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Yangtze River Pharmaceutical Group Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yangtze River Pharmaceutical Group Recent Developments
11.10 Hainan Poly Pharm
11.10.1 Hainan Poly Pharm Corporation Information
11.10.2 Hainan Poly Pharm Overview
11.10.3 Hainan Poly Pharm Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hainan Poly Pharm Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hainan Poly Pharm Recent Developments
11.11 Chongqing Huapont Pharmaceutical
11.11.1 Chongqing Huapont Pharmaceutical Corporation Information
11.11.2 Chongqing Huapont Pharmaceutical Overview
11.11.3 Chongqing Huapont Pharmaceutical Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Chongqing Huapont Pharmaceutical Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Chongqing Huapont Pharmaceutical Recent Developments
11.12 Dawnrays
11.12.1 Dawnrays Corporation Information
11.12.2 Dawnrays Overview
11.12.3 Dawnrays Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Dawnrays Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dawnrays Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antihistamine Medications Industry Chain Analysis
12.2 Antihistamine Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antihistamine Medications Production Mode & Process
12.4 Antihistamine Medications Sales and Marketing
12.4.1 Antihistamine Medications Sales Channels
12.4.2 Antihistamine Medications Distributors
12.5 Antihistamine Medications Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antihistamine Medications Industry Trends
13.2 Antihistamine Medications Market Drivers
13.3 Antihistamine Medications Market Challenges
13.4 Antihistamine Medications Market Restraints
14 Key Findings in The Global Antihistamine Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Antihistamines are medicines often used to relieve symptoms of allergies, such as hay fever, hives, conjunctivitis and reactions to insect bites or stings.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Antihistamine Medications is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Antihistamine Medications is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Antihistamine Medications is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Antihistamine Medications include Sanofi, Johnson And Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Sun Pharma, UCB Pharma and Yangtze River Pharmaceutical Group, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antihistamine Medications manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Antihistamine Medications market. Further, it explains the major drivers and regional dynamics of the global Antihistamine Medications market and current trends within the industry.

Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Sanofi
Johnson And Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Sun Pharma
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays

Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Antihistamine Medications Segment by Type
Oral
Non-Oral
Antihistamine Medications Segment by Application
Online
Offline

Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antihistamine Medications market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:
This report presents an overview of global market for Antihistamine Medications, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Antihistamine Medications, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Antihistamine Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antihistamine Medications sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Antihistamine Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Antihistamine Medications sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, Johnson And Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Sun Pharma, UCB Pharma and Yangtze River Pharmaceutical Group, etc.

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Antihistamine Medications in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Antihistamine Medications manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antihistamine Medications sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Antihistamine Medications Product Introduction
1.2 Market by Type
1.2.1 Global Antihistamine Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Non-Oral
1.3 Market by Application
1.3.1 Global Antihistamine Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antihistamine Medications Sales Estimates and Forecasts 2017-2028
2.2 Global Antihistamine Medications Revenue Estimates and Forecasts 2017-2028
2.3 Global Antihistamine Medications Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antihistamine Medications Sales by Region
2.4.1 Global Antihistamine Medications Sales by Region (2017-2022)
2.4.2 Global Sales Antihistamine Medications by Region (2023-2028)
2.5 Global Antihistamine Medications Revenue by Region
2.5.1 Global Antihistamine Medications Revenue by Region (2017-2022)
2.5.2 Global Antihistamine Medications Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antihistamine Medications Sales by Manufacturers
3.1.1 Global Top Antihistamine Medications Manufacturers by Sales (2017-2022)
3.1.2 Global Antihistamine Medications Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antihistamine Medications in 2021
3.2 Global Antihistamine Medications Revenue by Manufacturers
3.2.1 Global Antihistamine Medications Revenue by Manufacturers (2017-2022)
3.2.2 Global Antihistamine Medications Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antihistamine Medications Revenue in 2021
3.3 Global Antihistamine Medications Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antihistamine Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antihistamine Medications Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antihistamine Medications Sales by Type
4.1.1 Global Antihistamine Medications Historical Sales by Type (2017-2022)
4.1.2 Global Antihistamine Medications Forecasted Sales by Type (2023-2028)
4.1.3 Global Antihistamine Medications Sales Market Share by Type (2017-2028)
4.2 Global Antihistamine Medications Revenue by Type
4.2.1 Global Antihistamine Medications Historical Revenue by Type (2017-2022)
4.2.2 Global Antihistamine Medications Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antihistamine Medications Revenue Market Share by Type (2017-2028)
4.3 Global Antihistamine Medications Price by Type
4.3.1 Global Antihistamine Medications Price by Type (2017-2022)
4.3.2 Global Antihistamine Medications Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antihistamine Medications Sales by Application
5.1.1 Global Antihistamine Medications Historical Sales by Application (2017-2022)
5.1.2 Global Antihistamine Medications Forecasted Sales by Application (2023-2028)
5.1.3 Global Antihistamine Medications Sales Market Share by Application (2017-2028)
5.2 Global Antihistamine Medications Revenue by Application
5.2.1 Global Antihistamine Medications Historical Revenue by Application (2017-2022)
5.2.2 Global Antihistamine Medications Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antihistamine Medications Revenue Market Share by Application (2017-2028)
5.3 Global Antihistamine Medications Price by Application
5.3.1 Global Antihistamine Medications Price by Application (2017-2022)
5.3.2 Global Antihistamine Medications Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antihistamine Medications Market Size by Type
6.1.1 North America Antihistamine Medications Sales by Type (2017-2028)
6.1.2 North America Antihistamine Medications Revenue by Type (2017-2028)
6.2 North America Antihistamine Medications Market Size by Application
6.2.1 North America Antihistamine Medications Sales by Application (2017-2028)
6.2.2 North America Antihistamine Medications Revenue by Application (2017-2028)
6.3 North America Antihistamine Medications Market Size by Country
6.3.1 North America Antihistamine Medications Sales by Country (2017-2028)
6.3.2 North America Antihistamine Medications Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Antihistamine Medications Market Size by Type
7.1.1 Europe Antihistamine Medications Sales by Type (2017-2028)
7.1.2 Europe Antihistamine Medications Revenue by Type (2017-2028)
7.2 Europe Antihistamine Medications Market Size by Application
7.2.1 Europe Antihistamine Medications Sales by Application (2017-2028)
7.2.2 Europe Antihistamine Medications Revenue by Application (2017-2028)
7.3 Europe Antihistamine Medications Market Size by Country
7.3.1 Europe Antihistamine Medications Sales by Country (2017-2028)
7.3.2 Europe Antihistamine Medications Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antihistamine Medications Market Size by Type
8.1.1 Asia Pacific Antihistamine Medications Sales by Type (2017-2028)
8.1.2 Asia Pacific Antihistamine Medications Revenue by Type (2017-2028)
8.2 Asia Pacific Antihistamine Medications Market Size by Application
8.2.1 Asia Pacific Antihistamine Medications Sales by Application (2017-2028)
8.2.2 Asia Pacific Antihistamine Medications Revenue by Application (2017-2028)
8.3 Asia Pacific Antihistamine Medications Market Size by Region
8.3.1 Asia Pacific Antihistamine Medications Sales by Region (2017-2028)
8.3.2 Asia Pacific Antihistamine Medications Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Antihistamine Medications Market Size by Type
9.1.1 Latin America Antihistamine Medications Sales by Type (2017-2028)
9.1.2 Latin America Antihistamine Medications Revenue by Type (2017-2028)
9.2 Latin America Antihistamine Medications Market Size by Application
9.2.1 Latin America Antihistamine Medications Sales by Application (2017-2028)
9.2.2 Latin America Antihistamine Medications Revenue by Application (2017-2028)
9.3 Latin America Antihistamine Medications Market Size by Country
9.3.1 Latin America Antihistamine Medications Sales by Country (2017-2028)
9.3.2 Latin America Antihistamine Medications Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antihistamine Medications Market Size by Type
10.1.1 Middle East and Africa Antihistamine Medications Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antihistamine Medications Revenue by Type (2017-2028)
10.2 Middle East and Africa Antihistamine Medications Market Size by Application
10.2.1 Middle East and Africa Antihistamine Medications Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antihistamine Medications Revenue by Application (2017-2028)
10.3 Middle East and Africa Antihistamine Medications Market Size by Country
10.3.1 Middle East and Africa Antihistamine Medications Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antihistamine Medications Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Johnson And Johnson
11.2.1 Johnson And Johnson Corporation Information
11.2.2 Johnson And Johnson Overview
11.2.3 Johnson And Johnson Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson And Johnson Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson And Johnson Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Overview
11.4.3 Teva Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Teva Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Overview
11.6.3 Bayer Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bayer Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Recent Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Corporation Information
11.7.2 Sun Pharma Overview
11.7.3 Sun Pharma Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sun Pharma Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharma Recent Developments
11.8 UCB Pharma
11.8.1 UCB Pharma Corporation Information
11.8.2 UCB Pharma Overview
11.8.3 UCB Pharma Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 UCB Pharma Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 UCB Pharma Recent Developments
11.9 Yangtze River Pharmaceutical Group
11.9.1 Yangtze River Pharmaceutical Group Corporation Information
11.9.2 Yangtze River Pharmaceutical Group Overview
11.9.3 Yangtze River Pharmaceutical Group Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Yangtze River Pharmaceutical Group Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yangtze River Pharmaceutical Group Recent Developments
11.10 Hainan Poly Pharm
11.10.1 Hainan Poly Pharm Corporation Information
11.10.2 Hainan Poly Pharm Overview
11.10.3 Hainan Poly Pharm Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hainan Poly Pharm Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hainan Poly Pharm Recent Developments
11.11 Chongqing Huapont Pharmaceutical
11.11.1 Chongqing Huapont Pharmaceutical Corporation Information
11.11.2 Chongqing Huapont Pharmaceutical Overview
11.11.3 Chongqing Huapont Pharmaceutical Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Chongqing Huapont Pharmaceutical Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Chongqing Huapont Pharmaceutical Recent Developments
11.12 Dawnrays
11.12.1 Dawnrays Corporation Information
11.12.2 Dawnrays Overview
11.12.3 Dawnrays Antihistamine Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Dawnrays Antihistamine Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dawnrays Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antihistamine Medications Industry Chain Analysis
12.2 Antihistamine Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antihistamine Medications Production Mode & Process
12.4 Antihistamine Medications Sales and Marketing
12.4.1 Antihistamine Medications Sales Channels
12.4.2 Antihistamine Medications Distributors
12.5 Antihistamine Medications Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antihistamine Medications Industry Trends
13.2 Antihistamine Medications Market Drivers
13.3 Antihistamine Medications Market Challenges
13.4 Antihistamine Medications Market Restraints
14 Key Findings in The Global Antihistamine Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/05 10:26

151.38 円

159.59 円

194.97 円

ページTOPに戻る